Cargando…

Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP‐sponsored clinical trials before and after launch of the NCI National Clinical Trials Network

BACKGROUND: Participation of adolescents and young adults (AYAs) in oncology clinical trials is important to ensure adequate opportunities for AYA patients to contribute to, and benefit from, advances in cancer treatment. METHODS: Accrual data for National Cancer Institute (NCI) Cancer Therapy Evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sankaran, Hari, Finnigan, Shanda R., McShane, Lisa M., Best, Ana F., Seibel, Nita L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826149/ https://www.ncbi.nlm.nih.gov/pubmed/36089859 http://dx.doi.org/10.1002/cncr.34402

Ejemplares similares

Pharmacogenomics of in vitro response of the NCI-60 cancer cell line panel to Indian natural products
por: Sankaran, Hari, et al.
Publicado: (2022)

The New NCI Precision Medicine Trials
por: Harris, Lyndsay N., et al.
Publicado: (2023)

Investigating potential disparities in clinical trial eligibility and enrollment at an NCI‐designated comprehensive cancer center
por: Patel, Monica A., et al.
Publicado: (2023)

Prognostic and predictive factors associated with ipilimumab-related adverse events: a retrospective analysis of 11 NCI-sponsored phase I clinical trials
por: Chauhan, Aman, et al.
Publicado: (2020)

Molecular genomic features associated with in vitro response of the NCI‐60 cancer cell line panel to natural products
por: Krushkal, Julia, et al.
Publicado: (2020)

The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
por: Flaherty, Keith T, et al.
Publicado: (2020)

Overview and Utilization of the NCI Thesaurus
por: Fragoso, Gilberto, et al.
Publicado: (2004)

NCI Imaging Data Commons
por: Fedorov, Andrey, et al.
Publicado: (2021)

Tumor-specific activity of precision medicines in the NCI-MATCH trial
por: Zhou, Ivvone, et al.
Publicado: (2023)

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial
por: Mansfield, A. S., et al.
Publicado: (2022)

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
por: Johnson, J I, et al.
Publicado: (2001)

NCI–Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center
por: Kim, Daniel J., et al.
Publicado: (2020)

438. Dalbavancin Clinical Experience at an NCI Designated Cancer Center
por: McDaneld, Patrick, et al.
Publicado: (2019)

An anthropomorphic spine phantom for proton beam approval in NCI‐funded trials
por: Cho, Jongmin, et al.
Publicado: (2014)

İNTERNET 20'NCİ YAŞINI KUTLUYOR
Publicado: (2009)

İnternet 20`nci yaşını kutluyor
Publicado: (2009)

Biomarkers in phase I–II chemoprevention trials: lessons from the NCI experience
por: Szabo, Eva
Publicado: (2015)

Corrigendum to: The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Publicado: (2021)

NIEHS, NCI, and NIA Colaborate on Breast Cancer
Publicado: (1995)

On the Best Way to Cluster NCI-60 Molecules
por: Hernández-Hernández, Saiveth, et al.
Publicado: (2023)

Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study
por: Carlson, Josh J., et al.
Publicado: (2018)

Developing a model to predict accrual to cancer clinical trials: Data from an NCI designated cancer center
por: Iruku, Praveena, et al.
Publicado: (2019)

Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)‐affiliated clinical trials
por: Peterson, John S., et al.
Publicado: (2022)

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
por: Flaherty, Keith T., et al.
Publicado: (2020)

NIEHS Joins EPA and NCI in Agricultural Health Study
Publicado: (1993)

Detecting Role Errors in the Gene Hierarchy of the NCI Thesaurus
por: Min, Hua, et al.
Publicado: (2008)

Integrated metabolome and transcriptome analysis of the NCI60 dataset
por: Su, Gang, et al.
Publicado: (2011)

CTEP Versus LESS Totally Extraperitoneal Hernioplasty
por: Zhang, Haifeng, et al.
Publicado: (2018)

Patterns of National Cancer Institute‐Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults
por: Roth, Michael, et al.
Publicado: (2021)

NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures
por: Colen, Rivka, et al.
Publicado: (2014)

National Cancer Institute (NCI) Program for Natural Products Discovery: Rapid Isolation and Identification of Biologically Active Natural Products from the NCI Prefractionated Library
por: Grkovic, Tanja, et al.
Publicado: (2020)

National Cancer Institute (NCI) Program for Natural Product Discovery: Exploring NCI-60 Screening Data of Natural Product Samples with Artificial Neural Networks
por: Evans, Jason R., et al.
Publicado: (2023)

Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib – Results of NCI/CTEP Protocol 9048
por: Semrad, Thomas J, et al.
Publicado: (2019)

Annotation and query of tissue microarray data using the NCI Thesaurus
por: Shah, Nigam H, et al.
Publicado: (2007)

Recombination phenotypes of the NCI-60 collection of human cancer cells
por: Stults, Dawn M, et al.
Publicado: (2011)

NCI's provocative questions on cancer: some answers to ignite discussion
por: Blagosklonny, Mikhail V.
Publicado: (2011)

An integrated analysis of molecular aberrations in NCI-60 cell lines
por: Yeang, Chen-Hsiang
Publicado: (2010)

Expression of MicroRNAs in the NCI-60 Cancer Cell-Lines
por: Patnaik, Santosh K., et al.
Publicado: (2012)

Computational Challenges and Collaborative Projects in the NCI Quantitative Imaging Network
por: Farahani, Keyvan, et al.
Publicado: (2016)

Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines
por: Guo, Tiannan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g1pb66a9dthjis8c22abeis04o